Clicking the "View this Article" button will open the issue as a resizable PDF. To take the test for
the issue, return to this Introduction page and click the "Take the Test" button. The Introduction
page will remain open after you open this issue.
You may need to re-size or close the issue in order to see the Introduction page.
In 2021, insulin will celebrate its 100th anniversary. Yet a century after the discovery of insulin, the US is experiencing an escalation in the number of diabetes cases. In 2020, the Center for Disease Control and Prevention (CDC) reported that 34.2 million Americans (11% of the US population) have diabetes and 88 million American adults (35% of the US adult population) have prediabetes. New diabetes cases were higher among non-Hispanic blacks and people of Hispanic origin. Additionally, racial and ethnic minorities continue to develop type 2 diabetes at higher rates. The occurrence of diagnosed diabetes was highest among American Indians and Alaska Natives (14.7%), followed by people of Hispanic origin (12.5%), non-Hispanic blacks (11.7%), non-Hispanic Asians (9.2%) and non-Hispanic whites (7.5%). Coupled with the rising prevalence of diabetes is the obesity epidemic. Obesity is defined as a body mass index (BMI) greater than or equal to 30 kg/m; severe obesity is a BMI greater than or equal to 40 kg/m2. In 2017–2018, 42% of adults in the US were considered obese. By age group, the incidence was 40% for 20 - 39 year old adults; nearly 45% for 40 - 59 year old adults; and nearly 43% among adults 60 years and older. Both obesity and severe obesity were highest in non-Hispanic black adults and higher among women than men.
This program was developed by The Rx Consultant and published by Continuing Education Network, Inc. The Rx Consultant accepts no advertising or financial support from the pharmaceutical industry and is funded solely by the purchase of programs. The Rx Consultant is dedicated to providing unbiased, balanced information to health care practitioners.
Programs developed by The Rx Consultant are written by health care providers with expertise in the topic area, peer-reviewed, extensively edited, and fact-checked. This development process was created to insure that every program presents information that is current, accurate, relevant to "real world" health care providers, and written in an easy reading, "plain English" style.
The Rx Consultant is a publication of Continuing Education Network, Inc.
ACPE Universal Activity Number: 0428-0000-21-006-H01-P
Chief Editor and CE Administrator
Terry M. Baker, PharmD
Tracy Farnen, PharmD
James Chan, PharmD, PhD
Pharmacy Quality and Outcomes Coordinator
Associate Clinical Professor
Richard Ron Finley, B.S. Pharm.,R.Ph.
Consult Pharmacist Aging and Adult Health Services
Julio R. Lopez, PharmD, FCSHP
Adjunct Clinical Professor
Assistant Clinical Professor
Visiting Associate Professor and Lecturer
Pamela Mausner, MD
Helen Berlie, Pharm.D. CDE, BCACP
Ambulatory Care Specialist - Diabetes
Senior Editorial Advisor
Gerard Hatheway, PharmD, PhD
Belinda M. Danielson, RPh
Christopher M. DeSoto, PharmD
Angie S. Graham, PharmD
Cynthia Chan Huang, PharmD, MBA
Fred Plageman, PharmD
Editorial Advisor and Clinical Practice Consultant for Nurse Practitioners
Meuleman, RN, C, MS
Any hardware that supports Microsoft Windows, Apple Mac OS, iOS, or Android, and meets the software requirements.
Browser that supports TLS 1.1 + and PDF files.
This includes Microsoft Internet Explorer 11, Google Chrome 38, Google Android OS 5.0 Browser, Apple Safari (version 7 for desktop, 5 for mobile), Mozilla Firefox 27, newer versions of these browsers, as well as some earlier versions that may require additional configuration.
Adobe Acrobat Reader is recommended, and is required for some browsers.
Note: TLS 1.1 and 1.2 support is required for browser security. Click here for TLS browser support details.
Required. Broadband recommended. (T1, DSL, Cable, G4 or higher.)